About the Editor

Bentham Science Publishers

doi:10.2174/157017910791414508

Abstract

Jetze J. Tepe was born in Gouda, The Netherlands in 1968. He received his BS degree in 1992 from Jacksonville University, Florida and was awarded a PhD from the University of Virginia in 1998 where he worked with Prof. Timothy L. Macdonald on the design and synthesis of topoisomerase II inhibitors as potential chemotherapeutic agents. Following his PhD studies, he joined the laboratory of Prof. Robert M. Williams as a post-doctoral researcher, where he worked on the total synthesis and biological evaluation of various pyrrolizidine alkaloids and their analogues. In 2000, he joined the faculty at Michigan State University as an Assistant Professor and was promoted to Associate Professor in 2006. Research in the Tepe lab has been focused on the development of new heterocyclic reactions, cycloaddition reactions, and the synthesis and biological evaluation of novel heterocyclic natural products and analogues thereof. In 2003, he received the American Cancer Research Scholar award and in 2007 a Senior Award from the Multiple Myeloma Research Foundation. Dr Tepe is currently an editorial advisory board member of Current Bioactive Compounds. He is the co-Founder and Vice President of Research of TCH Pharmaceuticals (Ann Arbor, MI) and has served in various capacities including consultant and scientific advisory board member of several biotechnology corporations.